Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check46 days agoChange DetectedThe page has been updated to include the term 'Multiple Myeloma' and a new revision number, while significant background information about a Phase 3 study has been removed.SummaryDifference34%
- Check53 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed the date 2025-03-25 while adding the date 2024-12-24.SummaryDifference0.4%
- Check60 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new posting date of March 25, 2025, replacing the previous estimated dates and version. This indicates a significant update in the content's accuracy and reliability.SummaryDifference0.3%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.